Delivery Order SPE2DB20D1100-SPE2DB25FD2C8
Award Date 7/2/25
Potential Completion Date 7/24/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Bosulif 500 mg tablets (30-count units) under a firm fixed-price contract. The order carries a ceiling value of $11,301.40 and is scheduled for completion by September 25, 2025. This is a competitively awarded, non-set-aside delivery order with performance directed to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Bosulif 100 mg tablets (120-count units) with a ceiling value of $5,704.45. This firm fixed-price delivery order is scheduled for completion by August 22, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Bosulif 100 mg tablets (120-count units) with a contract ceiling value of $5,704.45. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The delivery order carries an ultimate completion date of October 2, 2025, and will be fulfilled from...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The order is for the supply of Bosulif 400 mg tablets, a specialty medication, at a firm fixed price of $21,910.86. The award is not associated with a set-aside program and has an ultimate completion date of September 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,408.90 to AmerisourceBergen Drug Corp for the supply of Bosulif 100 mg tablets (120-count units). This firm fixed-price contract, awarded on August 13, 2025, with an ultimate completion date of September 4, 2025, represents a non-set-aside, competitively awarded procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Bosulif is a prescription oncology...
- The Defense Logistics Agency awarded a $23,631.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Bosulif 400 mg tablets (30-count units). The contract, which has no set-aside designation, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,815.63 contract is for the delivery of Bosulif 400 mg tablets, a prescription medication. The award has a performance period ending on June 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support Medical, which allows the...
- AmerisourceBergen Drug Corp was awarded a competitively bid delivery order valued at $23,631.26 for BOSULIF 400 mg tablets (30-count packages) by the Defense Logistics Agency Medical Supply Chain on August 20, 2025, with an ultimate completion date of September 11, 2025. The contract employs firm fixed-price pricing with no set-aside designation, and performance will be executed from the contractor's Conshohocken, Pennsylvania location. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5.7 million to AmerisourceBergen Drug Corp for 120 tablets of Bosulif 100 mg, a pharmaceutical product used in cancer treatment. This firm fixed price, non-set-aside delivery order was awarded on May 12, 2025, with completion expected by June 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and operates as a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Bosulif 100 mg tablets (120-count units) with a contract ceiling value of $11,408.90. This firm fixed-price delivery order, with an ultimate completion date of October 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...